← Return to Recommendation for second opinion on prostate MRI scan?

Discussion
Comment receiving replies
@rockin2047

My Decipher score was 0.37 Low Risk with a tissue sample that was 3+4=7. However, the part that was rated a 4 by the pathologist was indicated as representing only 5% of the core. The two RO doctors I consulted with at different major hospitals were both, say, in their sixties. I mention this fact because when I consulted very recently with my urologist, he made a point in saying that "older" ROs usually push radiation treatment since that's how they were trained. My urologist who is in his 30s was not in this camp. While he would not commit to telling me what to do, the vibe I felt was to opt for Active Surveillance. He said most of his Low Risk patients are under AS. The idea is to monitor the prostate very closely using regular PSA testing and then have an MRI with biopsy either once a year (or maybe every other year). He highly recommended the free Prostate Cancer Patient Guide which is emailed to you from here https://www.pcf.org/guide/prostate-cancer-patient-guide/ Once you have it, go to page 37 where AS is discussed. For now, I plan to rely on AS. Then, if my PSA rises to a specific level I'll consider radiation using Viewray MRidian at the NewYork-Presbyterian David H. Koch Center in NYC. In addition, please read the encouraging results of this long term study https://www.nbcnews.com/news/us-news/study-finds-prostate-cancer-treatment-can-wait-men-rcna74512 MRidian has a number of locations in Florida: See https://viewray.com/for-patients/how-mridian-works/prostate/ Sorry for the slow response.

Jump to this post


Replies to "My Decipher score was 0.37 Low Risk with a tissue sample that was 3+4=7. However, the..."

Much appreciation for this info. I was looking at MRidian Viewray but saw bankruptcy notice last month and had given up on that approach. Someone on another forum indicated that Viewray had found a way to to continue treatment for patients. It certainly looked like one of most promising treatment options out there and hopefully still is.